US Company Recalls Chocolate Products Contaminated with Erectile Dysfunction Drugs
US Company Recalls Chocolate Products Containing Hidden Erectile Dysfunction Drugs
Ndtv
Image: Ndtv
Gear Isle, a San Francisco-based company, is recalling chocolate products after they were found to contain undeclared erectile dysfunction drugs sildenafil and tadalafil. The FDA warns that these ingredients can interact dangerously with certain heart medications, posing serious health risks to consumers.
- 01Gear Isle is recalling Gold Lion Aphrodisiac Chocolate and Ilum Sex Chocolate due to contamination with sildenafil and tadalafil.
- 02The FDA emphasizes the potential health risks of these undeclared ingredients, particularly for those using nitrate medications.
- 03No adverse reactions have been reported so far, but the company is coordinating returns and refunds.
- 04Sildenafil and tadalafil are phosphodiesterase type 5 inhibitors used to treat erectile dysfunction.
- 05Common side effects include headaches and indigestion, with rare cases of vision loss reported.
Advertisement
In-Article Ad
Gear Isle, a company based in San Francisco, is recalling its chocolate products, specifically Gold Lion Aphrodisiac Chocolate and Ilum Sex Chocolate, after they were found to contain undeclared active ingredients sildenafil and tadalafil, both used to treat erectile dysfunction. The U.S. Food and Drug Administration (FDA) announced the recall, highlighting the potential dangers these substances pose, especially for consumers who are taking nitrate medications for heart conditions. The FDA warns that combining these drugs can lead to a significant and potentially life-threatening drop in blood pressure. Although Gear Isle has not received any reports of adverse reactions, it is actively reaching out to customers to facilitate returns and refunds. The common side effects associated with sildenafil and tadalafil include headaches, indigestion, and nasal congestion, with rare instances of vision loss for sildenafil users. The recall serves as a critical reminder about the importance of transparency in dietary supplements.
Advertisement
In-Article Ad
Consumers who have purchased these products should be aware of the potential health risks and should return the products to avoid serious health issues.
Advertisement
In-Article Ad
Reader Poll
Are you concerned about the safety of dietary supplements?
Connecting to poll...
More about U.S. Food and Drug Administration
Trump Administration Threatens 100% Tariff on Imported Pharmaceuticals to Boost Domestic Production
The Economic Times • Apr 3, 2026

FDA to Reclassify Peptides: Implications for Skin Care and Beyond
Ndtv • Apr 1, 2026

RFK Jr. Advocates for Lifting FDA Ban on Controversial Peptide Treatments
Ars Technica • Apr 1, 2026
Read the original article
Visit the source for the complete story.




